Matches in Nanopublications for { ?s ?p "[Patients with previously untreated, recurrent, or metastatic SCCHN were treated with pemetrexed 500 mg/m(2) and bevacizumab 15 mg/kg given intravenously every 21 days with folic acid and B(12) supplementation until disease progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP674391.RAspZaZFhK6GFbHOjkAD2XuETOc1Pu7QTStNMRHlJDJzA130_assertion description "[Patients with previously untreated, recurrent, or metastatic SCCHN were treated with pemetrexed 500 mg/m(2) and bevacizumab 15 mg/kg given intravenously every 21 days with folic acid and B(12) supplementation until disease progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674391.RAspZaZFhK6GFbHOjkAD2XuETOc1Pu7QTStNMRHlJDJzA130_provenance.
- NP788523.RAFj1qBKJk92ARKePa5s047buUqe2SBuweM326AyHCl-U130_assertion description "[Patients with previously untreated, recurrent, or metastatic SCCHN were treated with pemetrexed 500 mg/m(2) and bevacizumab 15 mg/kg given intravenously every 21 days with folic acid and B(12) supplementation until disease progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788523.RAFj1qBKJk92ARKePa5s047buUqe2SBuweM326AyHCl-U130_provenance.